Literature DB >> 9459128

Increased serum levels of interleukin (IL)-5, IL-6 and IL-8 in bullous pemphigoid.

M Inaoki1, K Takehara.   

Abstract

Some cytokines have been suggested to take part in the blister formation in bullous pemphigoid (BP). However, the roles of the cytokines are only partly understood. To elucidate the involvement of cytokines in the immunological mechanisms in BP, we investigated the serum levels of interleukin (IL)-2, IL-4, IL-5, IL-6, IL-8, IL-13, soluble IL-2 receptor and soluble CD23 in patients with BP, and the correlation between cytokine levels and other clinical and laboratory data. Serum levels of these cytokines and soluble receptors were determined by enzyme-linked immunosorbent assay in 19 patients with BP and in 16 normal control subjects. Serum levels of IL-5 (P < 0.0001), IL-6 (P < 0.01) and IL-8 (P < 0.05) were significantly higher in BP patients than in the control subjects. Other cytokines and soluble receptor levels were not significantly different. Serum levels of IL-6 (P < 0.05) and IL-8 (P < 0.05) were significantly decreased after treatment when skin lesions disappeared. These results suggest that serum levels of IL-6 and IL-8 could be indicators of disease activity of BP.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9459128     DOI: 10.1016/s0923-1811(97)00044-3

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  14 in total

1.  Collagen XVII (BP180) modulates keratinocyte expression of the proinflammatory chemokine, IL-8.

Authors:  Françoise Van den Bergh; Steven L Eliason; Brian T Burmeister; George J Giudice
Journal:  Exp Dermatol       Date:  2012-08       Impact factor: 3.960

2.  Increased levels in vivo of mRNAs for IL-8 and macrophage inflammatory protein-1 alpha (MIP-1 alpha), but not of RANTES mRNA in peripheral blood mononuclear cells of patients with atopic dermatitis (AD).

Authors:  Y Hatano; K Katagiri; S Takayasu
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

3.  Hsp90 blockade modulates bullous pemphigoid IgG-induced IL-8 production by keratinocytes.

Authors:  Stefan Tukaj; Denise Grüner; Detlef Zillikens; Michael Kasperkiewicz
Journal:  Cell Stress Chaperones       Date:  2014-05-06       Impact factor: 3.667

4.  TSST-1+Staphylococcus aureus in Bullous Pemphigoid.

Authors:  Kelly N Messingham; Michael P Cahill; Samuel H Kilgore; Ananya Munjal; Patrick M Schlievert; Janet A Fairley
Journal:  J Invest Dermatol       Date:  2021-10-01       Impact factor: 7.590

5.  Eosinophil Cationic Protein (ECP), a predictive marker of bullous pemphigoid severity and outcome.

Authors:  Delphine Giusti; Gregory Gatouillat; Sébastien Le Jan; Julie Plée; Philippe Bernard; Frank Antonicelli; Bach Nga Pham
Journal:  Sci Rep       Date:  2017-07-06       Impact factor: 4.379

6.  Expression of the JAK/STAT Signaling Pathway in Bullous Pemphigoid and Dermatitis Herpetiformis.

Authors:  K Juczynska; A Wozniacka; E Waszczykowska; M Danilewicz; M Wagrowska-Danilewicz; J Wieczfinska; R Pawliczak; A Zebrowska
Journal:  Mediators Inflamm       Date:  2017-10-24       Impact factor: 4.711

7.  Proinflammatory Cytokine Gene Polymorphisms in Bullous Pemphigoid.

Authors:  Pardis-Sadat Tabatabaei-Panah; Hamideh Moravvej; Zahra Sadaf; Hadis Babaei; Maryam Geranmayeh; Sedigheh Hajmanouchehri; Ahmad Karimi; Fatemeh Sajjadi; Fereshteh Arghand; Ralf J Ludwig; Mareike Witte; Reza Akbarzadeh
Journal:  Front Immunol       Date:  2019-03-29       Impact factor: 7.561

8.  Cytokine and Chemokines Alterations in the Endemic Form of Pemphigus Foliaceus (Fogo Selvagem).

Authors:  Rodolfo Pessato Timóteo; Marcos Vinicius Silva; Djalma Alexandre Alves da Silva; Jonatas Da Silva Catarino; Fernando Henrique Canhoto Alves; Virmondes Rodrigues Júnior; Ana Maria Roselino; Helioswilton Sales-Campos; Carlo José Freire Oliveira
Journal:  Front Immunol       Date:  2017-08-14       Impact factor: 7.561

9.  High Index Values of Enzyme-Linked Immunosorbent Assay for BP180 at Baseline Predict Relapse in Patients With Bullous Pemphigoid.

Authors:  Hiroshi Koga; Kwesi Teye; Norito Ishii; Chika Ohata; Takekuni Nakama
Journal:  Front Med (Lausanne)       Date:  2018-05-09

Review 10.  The Role of Eosinophils in Bullous Pemphigoid: A Developing Model of Eosinophil Pathogenicity in Mucocutaneous Disease.

Authors:  Kyle T Amber; Manuel Valdebran; Khalaf Kridin; Sergei A Grando
Journal:  Front Med (Lausanne)       Date:  2018-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.